Use of botulinum toxin in the preventive and palliative treatment of the hips in children with infantile cerebral palsy

被引:6
|
作者
Pascual-Pascual, SI [1 ]
机构
[1] Hosp La Paz, Serv Neurol Pediat, Madrid, Spain
关键词
botulinum toxin; cerebral palsy; hip luxation; prevention and treatment; spasticity; spastic hip;
D O I
10.33588/rn.3701.2003225
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The bilateral spastic cerebral palsy (CP) usually produces hip abnormalities, already presents in many cases before 2 years of age, whose diagnostic requires X-ray because clinical exam do not detect some of them. The prognosis of CP hip disorders with conventional treatment is had, progressive, and limits the possibility of independent gait. Botulin toxin type A infiltrated in adductors, medial ischiotibials and iliopsoas, in addition to physiotherapy and orthosis, gives better results. Patients, methods and results. In our cases (98 cases, 193 hips) the natural evolution before (BT-A) treatment had been of progressive lateral migration of femoral head (86% got worse, and 11,4% became luxated), and after the onset of it the progression stopped in 74% of hips and reverted in other 14%. Conclusions. It is very important to start early the BT-A treatment and infiltrate systematically every 3-4 months in order to obtain good results. Stopping the treatment increase the chances of subluxation or luxation. BT-A is also a good treatment for hip pain in spastic CP.
引用
收藏
页码:80 / 82
页数:3
相关论文
共 50 条
  • [21] The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb
    Molenaers, Guy
    Van Campenhout, Anja
    Fagard, Katrien
    De Cat, Jos
    Desloovere, Kaat
    [J]. JOURNAL OF CHILDRENS ORTHOPAEDICS, 2010, 4 (03) : 183 - 195
  • [22] The use of botulinum toxin type A in children with cerebral palsy: a retrospective study
    Delgado, MR
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 : S11 - S18
  • [23] Use of botulinum toxin injection in 17 children with spastic cerebral palsy
    Wong, V
    [J]. PEDIATRIC NEUROLOGY, 1998, 18 (02) : 124 - 131
  • [24] Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment
    Molenaers, G
    Desloovere, K
    De Cat, J
    [J]. ORTHOPADE, 2004, 33 (10): : 1119 - +
  • [25] Computerized gait analysis of Botulinum Toxin treatment in children with cerebral palsy
    Galli, Manuela
    Cimolin, Veronica
    Valente, Enza Maria
    Crivellini, Marcello
    Ialongo, Tamara
    Albertin, Giorgio
    [J]. DISABILITY AND REHABILITATION, 2007, 29 (08) : 659 - 664
  • [26] EFFECTS OF BOTULINUM TOXIN-TYPE A IN THE TREATMENT OF CEREBRAL PALSY IN CHILDREN
    Dinu, Iuliana Stefania
    Seblany, Houssein Toufic
    Safer, Monica
    Plesca, Doina Anca
    [J]. FARMACIA, 2013, 61 (04) : 748 - 755
  • [27] Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy
    Strobl, Walter
    Theologis, Tim
    Brunner, Reinald
    Kocer, Serdar
    Viehweger, Elke
    Pascual-Pascual, Ignacio
    Placzek, Richard
    [J]. TOXINS, 2015, 7 (05): : 1629 - 1648
  • [28] TREATMENT WITH BOTULINUM TOXIN TYPE-A INJECTION IN CHILDREN WITH CEREBRAL PALSY
    Kuzmina, N.
    Rafikova, Z.
    Yuldashev, I.
    Sakhieva, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 147 - 147
  • [29] Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy
    Kay, RM
    Rethlefsen, SA
    Fern-Buneo, A
    Wren, TAL
    Skaggs, DL
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (11): : 2377 - 2384
  • [30] Long-term use of botulinum toxin type A in children with cerebral palsy: Treatment consistency
    Molenaers, Guy
    Schoerkhuber, Verena
    Fagard, Katrien
    Van Campenhout, Anja
    De Cat, Jos
    Pauwels, Petra
    Ortibus, Els
    De Cock, Paul
    Desloovered, Kaat
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (05) : 421 - 429